As of Jul 28
| +0.0172 / +2.85%|
The 3 analysts offering 12-month price forecasts for CytRx Corp have a median target of 3.00, with a high estimate of 10.00 and a low estimate of 0.75. The median estimate represents a +383.87% increase from the last price of 0.62.
The current consensus among 3 polled investment analysts is to Buy stock in CytRx Corp. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.